Short answer
Approximate detection windows.
These ranges are estimates. Detection depends on dose, duration of use, liver function, urine concentration, timing of the last dose, and the laboratory method used. A specific lab's cutoff matters more than a general internet table.
Why detection is long
Why Suboxone stays in the system as long as it does.
Buprenorphine has a mean elimination half-life of approximately 24 to 42 hours after Suboxone film is used sublingually or buccally. A half-life is the time it takes the body to reduce the amount of medication in the bloodstream by about half.
That does not mean the medication is “gone” after one half-life. After a dose, levels decline gradually over several days. This long half-life is one reason buprenorphine can usually be dosed once daily for opioid use disorder and why a missed dose does not always cause immediate withdrawal.
Most urine tests do not look only for buprenorphine. They often look for both:
- Buprenorphine: the parent medication.
- Norbuprenorphine: the main metabolite, which helps confirm that the medication was taken and metabolized.
Some confirmatory tests also report glucuronide metabolites. In clinical treatment, the pattern of buprenorphine and norbuprenorphine can sometimes help distinguish recent ingestion from possible urine spiking, but interpretation should be done by a clinician or laboratory familiar with buprenorphine testing.
Naloxone
Naloxone clears faster and is usually not the main testing issue.
Naloxone is included in Suboxone mainly to discourage injection or other misuse. When Suboxone is taken as directed under the tongue or against the cheek, naloxone exposure is much lower than buprenorphine exposure and usually contributes little to the medication’s treatment effect.
The Suboxone prescribing information reports a mean naloxone elimination half-life of approximately 2 to 12 hours after sublingual or buccal film use. Naloxone is not usually what standard workplace or routine clinical drug screens are measuring. When testing is ordered for Suboxone treatment, the main targets are usually buprenorphine and norbuprenorphine.
Naloxone is intended to deter injection of Suboxone. It can precipitate withdrawal or blunt opioid effects when injected by someone who is opioid-dependent, but it should not be described as a perfect safeguard.
Drug tests
Does Suboxone show up on a drug test?
Suboxone does not usually show up as “Suboxone.” If it is detected, the test is usually detecting buprenorphine and/or norbuprenorphine.
Standard workplace 5-panel tests do not usually include buprenorphine. Many standard 10-panel tests also do not include it unless buprenorphine has been specifically added. However, panel names are not fully standardized, and some legal, clinical, probation, pain-management, or treatment-program panels do include buprenorphine.
Standard opiate immunoassays are usually designed around morphine and codeine-type compounds and may miss many semi-synthetic and synthetic opioids, including buprenorphine. To detect Suboxone treatment reliably, the order usually needs to include a buprenorphine-specific screen or confirmatory test.
Buprenorphine-specific testing is common in:
- Addiction treatment programs.
- Drug courts and probation programs.
- Some pain management clinics.
- Some safety-sensitive workplace policies.
- Monitoring when medication adherence or diversion is a clinical concern.
What affects detection
What affects how long Suboxone stays in your system.
- Dose: Higher doses can extend detection time.
- Duration of treatment: Daily long-term use may extend urine detection compared with one-time use.
- Liver function: Buprenorphine is primarily metabolized by the liver, including CYP3A4 pathways. Moderate or severe hepatic impairment can affect exposure.
- Kidney function: Usually matters less for parent buprenorphine than liver function, but can affect urinary concentrations and some metabolites.
- Urine concentration: Dilute urine may lower measured concentration; concentrated urine may raise it.
- Body composition: Buprenorphine is lipophilic, so tissue distribution can influence clearance.
- Age and overall health: Older age and medical illness can slow clearance.
- Other medications: CYP3A4 inhibitors may increase buprenorphine levels; CYP3A4 inducers may lower them.
- Assay sensitivity: LC-MS/MS confirmatory testing detects lower concentrations than many point-of-care screens.
"Flushing it out"
Can you flush Suboxone out of your system?
No reliable method clears buprenorphine faster than your body’s normal metabolism. Drinking excessive water, intense exercise, saunas, and commercial cleansing or flushing products do not meaningfully shorten the biologic detection window.
Trying to dilute urine can create a dilute or invalid specimen, and excessive water intake can be medically unsafe. Time and the specific test cutoff are the main determinants.
If you take Suboxone as prescribed
If you are taking Suboxone as prescribed.
If you are taking Suboxone as prescribed for opioid use disorder, the medication staying in your system is the point. That is part of how it suppresses withdrawal and cravings between doses.
If you are concerned about a drug test:
- Ask the testing program whether buprenorphine is included.
- Keep documentation of your prescription.
- If the test is for employment, ask how prescribed medication is handled by the medical review officer (MRO) or testing administrator. Do not disclose more private health information to an employer than necessary.
- If a buprenorphine result could affect legal status, employment, housing, or custody, ask your prescriber whether a treatment letter is appropriate.
Medical note
This page is educational and does not replace medical care. Do not stop or change a buprenorphine prescription because of a drug test without talking to your prescriber. Stopping buprenorphine can cause withdrawal and can increase overdose risk if a person returns to illicit opioid use. Avoid combining buprenorphine with alcohol, benzodiazepines, or other sedatives unless a clinician is directly managing the risk.